Patents by Inventor Hiroshi Nishimune

Hiroshi Nishimune has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220396772
    Abstract: Embodiments of the present disclosure relate generally to the production of therapeutic mesenchymal stem cells (MSCs). More particularly, the present disclosure relates to the use of cell culture compositions and methods for generating MSCs that secrete neurotrophic factors and synaptic organizing agents for the treatment of neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS). As such, the present disclosure addresses the need for establishing a reliable source of therapeutic stem cells useful for the treatment of neurodegenerative diseases.
    Type: Application
    Filed: January 24, 2022
    Publication date: December 15, 2022
    Inventors: Hiroshi Nishimune, Richard Barohn, Buddhadeb Dawn, Yomna Badawi, James W. Mitchell, Rupal Soder
  • Patent number: 11286462
    Abstract: Embodiments of the present disclosure relate generally to the production of therapeutic mesenchymal stem cells (MSCs). More particularly, the present disclosure relates to the use of cell culture compositions and methods for generating MSCs that secrete neurotrophic factors and synaptic organizing agents for the treatment of neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS). As such, the present disclosure addresses the need for establishing a reliable source of therapeutic stem cells useful for the treatment of neurodegenerative diseases.
    Type: Grant
    Filed: September 14, 2018
    Date of Patent: March 29, 2022
    Assignee: University of Kansas
    Inventors: Hiroshi Nishimune, Richard Barohn, Buddhadeb Dawn, Yomna Badawi, James W. Mitchell, Rupal Soder
  • Publication number: 20200399610
    Abstract: Embodiments of the present disclosure relate generally to the production of therapeutic mesenchymal stem cells (MSCs). More particularly, the present disclosure relates to the use of cell culture compositions and methods for generating MSCs that secrete neurotrophic factors and synaptic organizing agents for the treatment of neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS). As such, the present disclosure addresses the need for establishing a reliable source of therapeutic stem cells useful for the treatment of neurodegenerative diseases.
    Type: Application
    Filed: September 14, 2018
    Publication date: December 24, 2020
    Inventors: Hiroshi Nishimune, Richard Barohn, Buddhadeb Dawn, Yomna Badawi, James W Mitchell, Rupal Soder